Silence Therapeutics

NASDAQ: SLN · Real-Time Price · USD
5.52
0.03 (0.64%)
At close: Aug 18, 2025, 3:59 PM
5.52
0.00%
After-hours: Aug 18, 2025, 04:10 PM EDT

Silence Therapeutics Revenue

Silence Therapeutics reported an annual revenue of $43.26M, reflecting a 70.47% growth. For the quarter ending March 31, 2025, Silence Therapeutics generated $142K in revenue.
Revenue (ttm)
43.26M
Revenue Growth
70.47%
Price / Sales Ratio
7.51
Revenue / Employee
372.91K
Employees
116
Market Cap
260.73M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 43.26M +70.47%
Dec 31, 2023 25.38M +44.99%
Dec 31, 2022 17.5M +40.97%
Dec 31, 2021 12.41M +126.59%
Dec 31, 2020 5.48M +2145.49%
Dec 31, 2019 244K +Infinity%
Dec 31, 2018 0 -100.00%
Dec 31, 2017 16K -97.92%
Dec 31, 2016 770K +Infinity%
Dec 31, 2015 0 -100.00%
Dec 31, 2014 15K -87.18%
Dec 31, 2013 117K -28.22%
Dec 31, 2012 163K -76.51%
Dec 31, 2011 694K -70.67%
Dec 31, 2010 2.37M +37.32%
Dec 31, 2009 1.72M -22.00%
Dec 31, 2008 2.21M -45.42%
Dec 31, 2007 4.05M +107.86%
Dec 31, 2006 1.95M +282.51%
Dec 31, 2005 509K +220.13%
Dec 31, 2004 159K -88.17%
Dec 31, 2003 1.34M +16.77%
Dec 31, 2002 1.15M +734.06%
Dec 31, 2001 138K -85.61%
Dec 31, 2000 959K -30.00%
Dec 31, 1999 1.37M +552.38%
Dec 31, 1998 210K +Infinity%
Dec 31, 1997 0 n/a
Dec 31, 1996 0 n/a
Dec 31, 1995 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.